Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Rizzo

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Bone Marrow Transplantation|April 1, 2003
Transplant center characteristics and clinical outcomes after hematopoietic stem cell transplantation: what do we know?F R Loberiza, D S Serna, M M Horowitz, et al.
Bone Marrow Transplantation|September 15, 2015
Survival of patients who develop solid tumors following hematopoietic stem cell transplantationM J Ehrhardt, R Brazauskas, W He, et al.
Hematology. American Society of Hematology. Education Program|November 28, 2001
Erythropoietin: a paradigm for the development of practice guidelinesJ D Rizzo, J Seidenfeld, M Piper, et al.
Oncology (Williston Park, N.Y.)|June 9, 2001
Transplant registries: guiding clinical decisions and improving outcomesM M Horowitz, F R Loberiza, C N Bredeson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Outpatient-based bone marrow transplantation for hematologic malignancies: cost saving or cost shifting?J D Rizzo, G B Vogelsang, S Krumm, et al.
Bone Marrow Transplantation|May 22, 2001
Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databasesP Anderlini, J D Rizzo, M L Nugent, et al.
Bone Marrow Transplantation|May 10, 2016
Can we agree on patient-reported outcome measures for assessing hematopoietic cell transplantation patients? A study from the CIBMTR and BMT CTNB E Shaw, S J Lee, M M Horowitz, et al.
Bone Marrow Transplantation|May 19, 2010
High probability of long-term survival in 2-year survivors of autologous hematopoietic cell transplantation for AML in first or second CRN S Majhail, R Bajorunaite, H M Lazarus, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
In vitro anti-human immunodeficiency virus (HIV) activity of the chromanone derivative, 12-oxocalanolide A, a novel NNRTIZ Q Xu, R W Buckheit, T L Stup, et al.
Bone Marrow Transplantation|January 26, 2006
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT)J D Rizzo, J R Wingard, A Tichelli, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Bone Marrow Transplantation|April 1, 2003
Transplant center characteristics and clinical outcomes after hematopoietic stem cell transplantation: what do we know?F R Loberiza, D S Serna, M M Horowitz, et al.
Bone Marrow Transplantation|September 15, 2015
Survival of patients who develop solid tumors following hematopoietic stem cell transplantationM J Ehrhardt, R Brazauskas, W He, et al.
Hematology. American Society of Hematology. Education Program|November 28, 2001
Erythropoietin: a paradigm for the development of practice guidelinesJ D Rizzo, J Seidenfeld, M Piper, et al.
Oncology (Williston Park, N.Y.)|June 9, 2001
Transplant registries: guiding clinical decisions and improving outcomesM M Horowitz, F R Loberiza, C N Bredeson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Outpatient-based bone marrow transplantation for hematologic malignancies: cost saving or cost shifting?J D Rizzo, G B Vogelsang, S Krumm, et al.
Bone Marrow Transplantation|May 22, 2001
Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databasesP Anderlini, J D Rizzo, M L Nugent, et al.
Bone Marrow Transplantation|May 10, 2016
Can we agree on patient-reported outcome measures for assessing hematopoietic cell transplantation patients? A study from the CIBMTR and BMT CTNB E Shaw, S J Lee, M M Horowitz, et al.
Bone Marrow Transplantation|May 19, 2010
High probability of long-term survival in 2-year survivors of autologous hematopoietic cell transplantation for AML in first or second CRN S Majhail, R Bajorunaite, H M Lazarus, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
In vitro anti-human immunodeficiency virus (HIV) activity of the chromanone derivative, 12-oxocalanolide A, a novel NNRTIZ Q Xu, R W Buckheit, T L Stup, et al.
Bone Marrow Transplantation|January 26, 2006
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT)J D Rizzo, J R Wingard, A Tichelli, et al.
Pageof 4